raloxifene hydrochloride has been researched along with benzofurans in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carley, W; Chen, J; Katti, S; Mader, MM; Marrero, D; Moehler, U; Muegge, I; Smith, RA; Stirtan, WG; Weaver, DR; Xiao, H | 1 |
Endo, Y; Furuya, K; Ishige, H; Kuzutani, K; Makino, A; Morikyu, T; Ohyabu, Y; Yamamoto, N | 1 |
2 other study(ies) available for raloxifene hydrochloride and benzofurans
Article | Year |
---|---|
Solid-phase synthesis and investigation of benzofurans as selective estrogen receptor modulators.
Topics: Benzofurans; Breast Neoplasms; Cell Line; Drug Design; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Models, Molecular; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2002 |
The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats.
Topics: Alendronate; Androgens; Animals; Benzofurans; Bone and Bones; Bone Density; Bone Density Conservation Agents; Drug Interactions; Female; Male; Parathyroid Hormone; Quinolines; Rabbits; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Steroid; Selective Estrogen Receptor Modulators; Teriparatide | 2012 |